Welcome to the website and services provided by NCV Media, LLC,
(“New Cannabis Ventures”), which can be found at www.newcannabisventures.com, (the “Site”).

New Cannabis Ventures connects the cannabis industry through curated content on only the most promising cannabis companies and the most influential investors, allowing its visitors to save time as they stay on top of the latest trends in this dynamic industry. Curated content that gets published ranges from company specific to industry wide news, as well as information, opinion, analysis and commentary.

The Site and any information therein are provided without warranty of any kind, including the implied warranties of merchantability, fitness for use of a particular purpose, accuracy, or non-infringement. New Cannabis Ventures does not guarantee that the Site will operate in an uninterrupted or error-free manner or is free of viruses or other harmful components. Use of information obtained from or through the Site is at your own risk. The Site is not liable for any loss or damages including, but not limited to, claims for defamation, errors, loss of data, loss of money, or interruption in availability of data arising out of the use or inability to use the Site or any links; to your placement of content on the Site; or to your reliance upon information obtained from or through the Site or through links contained on the Site.

This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. New Cannabis Ventures does not condone the use of cannabis except where permissible by state law. The Site does not possess, distribute, or sell cannabis products.

Public disclosure
New Cannabis Ventures may publish content on publicly-traded companies, but does not accept any form of compensation from them unless disclosed here: ABcann – Start date: 04/24/17 (as a public company), Aurora Cannabis – Start date: 10/1/16, Canopy Growth Corporation – Start date: 10/1/16, Emblem Corp. – Start date: 12/12/16 (as a public company), Emerald Health – 01/16/17-03/31/17, GrowGeneration – Start date: 01/01/17, Harvest One Cannabis – Start date: 04/01/17, iAnthus Capital Holdings – Start date 04/20/17, Kush Bottles – Start date 02/15/17, Maricann Group – Start date: 04/22/17 (as a public company), OrganiGram – 01/01/17-03/31/17, Solis Tek – Start date 04/16/17, Therapix Biosciences – Start date 03/22/17

Responsible awareness
New Cannabis Ventures is proud to offer fact-based, data-driven, financial information and official company news about each publicly-traded client. This can be accessed by visiting a clients “Investor Dashboard”. The goal is to ensure the reader has the most up to date and factual information that is publicly available. All data and info is provided “as is” and solely for informational purposes, not for trading or advice.

Publicly-traded client criteria
Please note well, being a client of New Cannabis Ventures is not a recommendation of the company. In determining which public companies are eligible to be a client of New Cannabis Ventures, they must meet a minimum standard. Meeting these criteria is not a guarantee that New Cannabis Ventures will accept a company as a client. Note that there are slightly different standards for licensed producers in Canada:

U.S. Criteria

  • $1 minimum stock price for annual sales <$5mm
  • $0.10 minimum stock price for annual sales >$5mm
  • No history of stock promotion
  • No toxic debt
  • Current in SEC filings

Canadian LP Criteria

  • A license issued by Health Canada
  • A demonstrated capacity to raise capital
  • No history of stock promotion
  • No toxic debt
  • Current in SEDAR filings
Latest News
Get The App

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.



NCV Media, LLC

Thank you for reading

New Cannabis Ventures

Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors.